Fund HoldingsCAXTON CORP

Total Portfolio Value
$26.32M
Total Bought
$1.35M
Total Sold
$4.49M
Net Transaction
-$3.14M
Filing Period:
Securities
SharesValue ($K)
Q2 2023
Q3 2023
Change
Q2 2023
Q3 2023
Weight (%)
Change
MOLECULAR TEMPLATES INC0136,866+136,86608653.29%+865
APOGEE THERAPEUTICS INC(APGE)012,472+12,47202661.01%+266
ACLARIS THERAPEUTICS INC(ACRS)019,473+19,47301330.51%+133
ALLAKOS INC17,73349,329+31,596771120.43%+35
COMPASS THERAPEUTICS INC43,46686,773+43,3071381710.65%+33
ELEVATION ONCOLOGY INC21,72521,813+8833140.05%-19
REZOLUTE INC1,318,9671,318,96702,6121,7416.61%-871
MOLECULAR TEMPLATES INC2,052,9910-2,052,9919850-985
SAVARA INC(SVRA)4,980,8043,313,602-1,667,20216,02612,52547.59%-3,501
XERIS BIOPHARMA HOLDINGS INC5,641,9205,641,920014,78210,49439.87%-4,288
Page 1 of 1